A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Therapy in Patients With Diabetic Gastroparesis

May 01, 2019
https://clinicaltrials.gov/ct2/show/NCT03285308
Gastroenterology Hepatology
Principal Investigator: Eva H Alsheik, MD
Diabetic Gastroparesis, gastroparesis, paresis
Open